Alvine Pharmaceuticals Initiates Phase I Trial For ALV003
Alvine Pharmaceuticals, Inc., a biopharmaceutical company focused on the treatment of autoimmune and gastrointestinal diseases, announced that the first study subject was dosed in a Phase 1 clinical trial of its lead clinical candidate ALV003 which is in development for the treatment of patients with celiac disease. ALV003 is an orally administered combination of two proteases engineered to detoxify gluten.
In a sharp turnaround, the Republican candidates has opened a 5-point lead on his Democratic rival and is seen as a stronger manager of the economy, according to a Reuters/Zogby poll.
AFP - Georgia's South Ossetia and Abkhazia regions planned rallies Thursday to ask Russia for recognition as independent states, two weeks after Russian troops occupied both provinces.
